Using NI-ES to Treat Spinal Cord Injury (SCI)

NCT04097015 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2019-10-08

No results posted yet for this study

Summary

NI-ES therapy is a treatment that is being studied to potentially treat pain associated with SCI and may help movement below the injury site.

Conditions

  • Spinal Cord Injuries
  • Pain, Neuropathic

Interventions

DEVICE

Alpha-Stim M

Alpha-Stim M with and Ocular Interface and a Spinal Interface

Sponsors & Collaborators

  • DuBois Vision Clinic

    collaborator OTHER
  • SCI Research Advancement

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-20
Primary Completion
2019-10-31
Completion
2019-11-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04097015 on ClinicalTrials.gov